BIOMAT Database Logo BIOMAT Database Logo

Methotrexate as an adjuvant treatment for pemphigus vulgaris. 1999

T J Smith, and J C Bystryn

UI MeSH Term Description Entries
D008297 Male Males
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010392 Pemphigus Group of chronic blistering diseases characterized histologically by ACANTHOLYSIS and blister formation within the EPIDERMIS. Pemphigus Vulgaris,Pemphigus Foliaceus,Foliaceus, Pemphigus
D003879 Dermatologic Agents Drugs used to treat or prevent skin disorders or for the routine care of skin. Agent, Dermatologic,Agent, Dermatological,Agents, Dermatologic,Dermatologic Agent,Dermatological Agents,Agents, Dermatological,Dermatological Agent
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017024 Chemotherapy, Adjuvant Drug therapy given to augment or stimulate some other form of treatment such as surgery or radiation therapy. Adjuvant chemotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment. Adjuvant Chemotherapy,Drug Therapy, Adjuvant,Adjuvant Drug Therapy

Related Publications

T J Smith, and J C Bystryn
Methotrexate is an effective and safe adjuvant therapy for pemphigus vulgaris.
January 2012, European journal of dermatology : EJD,
T J Smith, and J C Bystryn
Omalizumab as adjuvant therapy for pemphigus vulgaris.
August 2022, Dermatologic therapy,
T J Smith, and J C Bystryn
Treatment of pemphigus vulgaris with methotrexate.
July 1969, Archives of dermatology,
T J Smith, and J C Bystryn
Assessing the use of methotrexate as an alternate therapy for pemphigus vulgaris and pemphigus foliaceus.
August 2022, Dermatologic therapy,
T J Smith, and J C Bystryn
Mycophenolate mofetil as adjuvant in pemphigus vulgaris.
January 2007, Indian journal of dermatology, venereology and leprology,
T J Smith, and J C Bystryn
The use of rituximab as an adjuvant in the treatment of oral pemphigus vulgaris.
January 2020, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology,
T J Smith, and J C Bystryn
Etanercept plus methotrexate: An effective combination therapy for recalcitrant pemphigus vulgaris.
March 2015, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences,
T J Smith, and J C Bystryn
[Pemphigus vulgaris--an alternative for steroid treatment?].
July 2006, Harefuah,
T J Smith, and J C Bystryn
Immunocytometric Analysis of Oral Pemphigus vulgaris Patients after Treatment with Rituximab as Adjuvant.
November 2021, Biomolecules,
T J Smith, and J C Bystryn
[Treatment of pemphigus vulgaris and non-acantholytic pemphigus with methotrexate (review of the literature)].
February 1971, Vestnik dermatologii i venerologii,
Copied contents to your clipboard!